Literature DB >> 21087954

Stereotactic radiosurgery for AMD: a Monte Carlo-based assessment of patient-specific tissue doses.

Justin Hanlon1, Michael Firpo, Erik Chell, Darius M Moshfeghi, Wesley E Bolch.   

Abstract

PURPOSE: To define the radiation doses to nontargeted ocular and adnexal tissues with Monte-Carlo simulation using a stereotactic low-voltage x-ray irradiation system for the treatment of wet age-related macular degeneration.
METHODS: Thirty-two right/left eye models were created from three-dimensional reconstructions of 1-mm computed tomography images of the head and orbital region. The resultant geometric models were voxelized and imported to the MCNPX 2.5.0 radiation transport code for Monte Carlo-based simulations of AMD treatment. Clinically, treatment is delivered noninvasively by three divergent 100-kVp photon beams entering through the sclera and overlapping on the macula cumulating in a therapeutic dose. Tissue-averaged doses, localized point doses, and color-coded dose contour maps are reported from Monte Carlo simulations of x-ray energy deposition for several tissues of interest, including the lens, optic nerve, macula, brain, and orbital bone.
RESULTS: For all eye models in this study (n = 32), tissues at risk did not receive tissue-averaged doses over the generally accepted thresholds for serious complication, specifically the formation of cataracts or radiation-induced optic neuropathy. Dose contour maps are included for three patients, each from separate groups defined by coherence to clinically realistic treatment setups. Doses to the brain and orbital bone were found to be insignificant.
CONCLUSIONS: The computational assessment performed indicates that a previously established therapeutic dose can be delivered effectively to the macula with the scheme described so that the potential for complications to nontargeted radiosensitive tissues might be reduced.

Entities:  

Mesh:

Year:  2011        PMID: 21087954     DOI: 10.1167/iovs.10-6421

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  The role of simulation in neurosurgery.

Authors:  Roberta Rehder; Muhammad Abd-El-Barr; Kristopher Hooten; Peter Weinstock; Joseph R Madsen; Alan R Cohen
Journal:  Childs Nerv Syst       Date:  2015-10-05       Impact factor: 1.475

2.  Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD.

Authors:  Justin L Cantley; Justin Hanlon; Erik Chell; Choonsik Lee; W Clay Smith; Wesley E Bolch
Journal:  Phys Med Biol       Date:  2013-09-12       Impact factor: 3.609

3.  Nanoparticle-aided Radiotherapy for Retinoblastoma and Choroidal Melanoma.

Authors:  Yucel Altundal; Erno Sajo; G Mike Makrigiorgos; Ross I Berbeco; Wilfred Ngwa
Journal:  IFMBE Proc       Date:  2015

4.  Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation.

Authors:  D Brivio; P Zygmanski; M Arnoldussen; J Hanlon; E Chell; E Sajo; G M Makrigiorgos; W Ngwa
Journal:  Phys Med Biol       Date:  2015-11-18       Impact factor: 3.609

Review 5.  Targeted radiotherapy with gold nanoparticles: current status and future perspectives.

Authors:  Wilfred Ngwa; Rajiv Kumar; Srinivas Sridhar; Houari Korideck; Piotr Zygmanski; Robert A Cormack; Ross Berbeco; G Mike Makrigiorgos
Journal:  Nanomedicine (Lond)       Date:  2014-05       Impact factor: 5.307

6.  StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.

Authors:  James E Neffendorf; Riti Desai; Yanzhong Wang; Joanna Kelly; Caroline Murphy; Barnaby C Reeves; Usha Chakravarthy; Sarah Wordsworth; Cornelius Lewis; Janet Peacock; Shahir Uddin; Joe M O'Sullivan; Timothy L Jackson
Journal:  Trials       Date:  2016-11-24       Impact factor: 2.279

7.  In vitro evaluation of simulated stereotactic radiotherapy for wet age-related macular degeneration on three different cell lines.

Authors:  Efstathios Vounotrypidis; Anna Hillenmayer; Christian M Wertheimer; Alexis Athanasiou; Jakob Siedlecki; Michael Orth; Andreas Ohlmann; Siegfried G Priglinger; Armin Wolf
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

8.  Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD.

Authors:  Katja Hatz; Frank Zimmermann; Emmanouil Lazaridis; Dimitrios Kardamakis; Magdalena Guichard; Cengiz Türksever; Christian Pruente; Ursula Margarethe Schmidt-Erfurth; Bianca S Gerendas
Journal:  Br J Ophthalmol       Date:  2020-12-21       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.